Nicole Murphy - Mar 31, 2023 Form 4 Insider Report for BIOGEN INC. (BIIB)

Role
Head of Pharm Ops and Tech
Signature
/s/ Wendell Taylor, attorney in fact for Nicole Murphy
Stock symbol
BIIB
Transactions as of
Mar 31, 2023
Transactions value $
-$32,251
Form type
4
Date filed
4/4/2023, 05:21 PM
Previous filing
Feb 22, 2023
Next filing
Jan 31, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIIB Common Stock Options Exercise $0 +239 +4.28% $0.00 5.82K Mar 31, 2023 Direct F1
transaction BIIB Common Stock Tax liability -$32.3K -116 -1.99% $278.03 5.7K Mar 31, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIIB Restricted Stock Unit Options Exercise $0 -239 -49.9% $0.00 240 Mar 31, 2023 Common Stock 239 $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 91.6992 shares acquired under the Biogen Inc. employee stock purchase plan.
F2 This award was granted to the reporting person on April 1, 2021. The remaining portion of the award vests in equal installments on each of the second and third anniversary of the grant date.